Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yew, Kok Hooi ^a   Crow, Jennifer ^a   Hirst, Jeff ^a   Pressetto, Ziyan ^a   Godwin, Andrew K ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CARBOPLATIN; CARRIER PROTEIN; CYTOKERATIN 19; DYSTROGLYCAN; EPITHELIAL CELL ADHESION MOLECULE; KRUPPEL LIKE FACTOR 4; LAMININ; MATRIX METALLOPROTEINASE 16; MESSENGER RNA; MUCIN 1; OCCLUDIN; PALLADIN; PLATINUM COMPLEX; SYNTAXIN 2; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME SYNTHESIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; CARBOPLATIN; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 3; OVARIAN NEOPLASMS; PHENOTYPE; SYNTAXIN 1; TRANSCRIPTOME;

EID: 84883609923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072637     Document Type: Article

References (37)

1. Ahmed N, Abubaker K, Findlay J, Quinn M, (2010) Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 10: 268-278.
2. Latifi A, Abubaker K, Castrechini N, Ward AC, Lionque C, et al. (2011) Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. J Cell Biochem 112: 2850-2864.
3. Strauss R, Li ZY, Liu Y, Beyer I, Persson J, et al. (2011) Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 6: e16186.
4. Hirai Y, Takebe K, Takashina M, Kobayashi S, Takeichi M, (1992) Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell 69: 471-481.
5. Tulachan SS, Doi R, Hirai Y, Kawaguchi Y, Koizumi M, et al. (2006) Mesenchymal epimorphin is important for pancreatic duct morphogenesis. Dev Growth Differ 48: 65-72.
6. Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, et al. (1998) Epimorphin functions as a key morphoregulator for mammary epithelial cells. J Cell Biol 140: 159-169.
7. Koshida S, Hirai Y, (1997) Identification of cellular recognition sequence of epimorphin and critical role of cell/epimorphin interaction in lung branching morphogenesis. Biochem Biophys Res Commun 234: 522-525.
8. Fritsch C, Swietlicki EA, Lefebvre O, Kedinger M, Iordanov H, et al. (2002) Epimorphin expression in intestinal myofibroblasts induces epithelial morphogenesis. J Clin Invest 110: 1629-1641.
9. von Schalburg KR, McCarthy SP, Rise ML, Hutson JC, Davidson WS, (2006) et.al (2006) Expression of morphogenic genes in mature ovarian and testicular tissues: potential stem-cell niche markers and patterning factors. Mol Reprod Dev 73: 142-152.
10. Hirai Y, Nelson CM, Yamazaki K, Takebe K, Przybylo J, et al. (2007) Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelial morphogenesis. J Cell Sci 120: 2032-2043.
11. Iizuka M, Sasaki K, Hirai Y, Shindo K, Konno S, et al. (2007) Morphogenic protein epimorphin protects intestinal epithelial cells from oxidative stress by the activation of EGF receptor and MEK/ERK, PI3 kinase/Akt signals. Am J Physiol Gastrointest Liver Physiol 292: G39-G52.
12. Hirai Y, Radisky D, Boudreau R, Simian M, Stevens ME, et al. (2001) Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta. J Cell Biol 153: 785-794.
13. Miura K, Yoshino R, Hirai Y, Goto T, Ohshima S, et al. (2007) Epimorphin, a morphogenic protein, induces proteases in rodent hepatocytes through NF-kappaB. J Hepatol 47: 834-843.
14. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, et al. (2001) The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 128: 3117-3131.
15. Okugawa Y, Hirai Y, (2008) Overexpression of extracellular epimorphin leads to impaired epidermal differentiation in HaCaT keratinocytes. J Invest Dermatol 128: 1884-1893.
16. Yori JL, Johnson E, Zhou G, Jain MK, Keri RA, (2010) Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 285: 16854-16863.
17. Birsoy K, Chen Z, Friedman J, (2008) Transcriptional regulation of adipogenesis by KLF4. Cell Metab 7: 339-347.
18. Feinberg MW, Cao Z, Wara AK, Lebedeva MA, Senbanerjee S, et al. (2005) Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem 280: 38247-38258.
19. Roos AB, Berg T, Barton JL, Didon L, Nord M, (2012) Airway epithelial cell differentiation during lung organogenesis requires C/EBPα and C/EBPβ. Dev Dyn 241: 911-923.
20. Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, et al. (2001) Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell 12: 1445-1455.
21. Johnson SW, Laub PB, Beesley JS, Ozols RF, Hamilton TC, (1997) Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res 57: 850-856.
22. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
23. Vainio S, Heikkilä M, Kispert A, Chin N, McMahon AP, (1999) Female development in mammals is regulated by Wnt-4 signalling. Nature 397: 405-409.
24. Mucenski ML, Wert SE, Nation JM, Loudy DE, Huelsken J, et al. (2003) beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis. J Biol Chem 278: 40231-40238.
25. van Heerde WL, de Groot PG, Reutelingsperger CP, (1995) The complexity of the phospholipid binding protein Annexin V. Thromb Haemost. 73: 172-179.
26. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C, (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184: 39-51.
27. Ahmed N, Thompson EW, Quinn MA, (2007) Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 213: 581-588.
28. Park SM, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
29. Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF, (2011) Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol Oncol 121: 200-205.
30. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, et al. (1999) E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A 96: 6249-6254.
31. Chen CS, Nelson CM, Khauv D, Bennett S, Radisky ES, et al. (2009) Homology with vesicle fusion mediator syntaxin-1a predicts determinants of epimorphin/syntaxin-2 function in mammary epithelial morphogenesis. J Biol Chem 284: 6877-6884.
32. Robinson GW, Johnson PF, Hennighausen L, Sterneck E, (1998) The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev 12: 1907-1916.
33. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
34. Pan JJ, Yang MH, (2011) The role of epithelial-mesenchymal transition in pancreatic cancer. J Gastrointest Oncol 2: 151-156.
35. Li Y, VandenBoom TG 2nd, Kong D, Wang Z, Ali S, et al. (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69: 6704-6712.
36. Marchini S, Fruscio R, Clivio L, Beltrame L, Porcu L, et al. (2013) Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Eur J Cancer 49: 520-530.
37. Ashe HL, Briscoe J, (2006) The interpretation of morphogen gradients. Development 133: 385-394.